Evidence map›Paper›PMID 35031607›Full record

ArticleNature communications2022

Transcriptional programs regulating neuronal differentiation are disrupted in DLG2 knockout human embryonic stem cells and enriched for schizophrenia and related disorders risk variants.

Bret Sanders, Daniel D'Andrea, Mark O Collins, Elliott Rees, Tom G J Steward, Ying Zhu, Gareth Chapman, Sophie E Legge, Antonio F Pardiñas, Adrian J Harwood and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Transcriptomic identification and developmental mapping ofTurkish journal of biology = Turk biyoloji dergisi · 2026
    Article
  4. Article
  5. Article
  6. Autism risk genes converge onbioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Bret SandersNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK.
Daniel D'AndreaMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0002-7843-3856
Mark O CollinsDepartment of Biomedical Science, University of Sheffield, Sheffield, S10 2TN, UK.ORCID http://orcid.org/0000-0002-7656-4975
Elliott ReesMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, CF24 4HQ, UK.
Tom G J StewardBristol Medical School, University of Bristol, Bristol, BS1 3NY, UK.ORCID http://orcid.org/0000-0002-7515-1706
Ying ZhuNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK.
Gareth ChapmanNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK.
Sophie E LeggeMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0001-6617-0289
Antonio F PardiñasMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0001-6845-7590
Adrian J HarwoodNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK.
William P GrayNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0001-7595-8887
Michael C O'DonovanMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0001-7073-2379
Michael J OwenNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0003-4798-0862
Adam C ErringtonNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK.
Derek J BlakeMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0002-5005-4731
Daniel J WhitcombBristol Medical School, University of Bristol, Bristol, BS1 3NY, UK.ORCID http://orcid.org/0000-0003-2703-1643
Andrew J PocklingtonMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, CF24 4HQ, UK. pocklingtonaj@cardiff.ac.uk.ORCID http://orcid.org/0000-0002-2137-0452
Eunju ShinNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK. e.shin@keele.ac.uk.ORCID http://orcid.org/0000-0002-8865-6834
Cardiff University · GBUniversity of Bristol · GBKeele University · GBUniversity of Sheffield · GB

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
NATIONAL ALZHEIMERS COORDINATING CENTER (NACC)U01AG016976 · NIA · UNIVERSITY OF WASHINGTON · PI KUKULL, WALTER ANTHONY · 1999 to 2020
$72.8M
Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
CHARGE Consortium: Omics Discovery for CVD and Aging PhenotypesR01HL105756 · NHLBI · UNIVERSITY OF WASHINGTON · PI Bruce M Psaty, NICHOLAS L SMITH · 2011 to 2026
$9.5M
Collaborative GWAS of Dementia, AD and related MRI and Cognitive EndophenotypesR01AG033193 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SESHADRI, SUDHA · 2009 to 2016
$4.4M
Medical Research Council 503480Medical Research Council G0300356Medical Research Council G08005009Medical Research Council MR/L010305/1NHLBI NIH HHS R01 HL105756NIA NIH HHS R01 AG033193NIA NIH HHS U01 AG016976NIA NIH HHS U01 AG032984NIA NIH HHS U24 AG021886Wellcome TrustWellcome Trust 082604/2/07/ZWellcome Trust (Wellcome) 100202/Z/12/Z
6 · The paper itself

Abstract

Coordinated programs of gene expression drive brain development. It is unclear which transcriptional programs, in which cell-types, are affected in neuropsychiatric disorders such as schizophrenia. Here we integrate human genetics with transcriptomic data from differentiation of human embryonic stem cells into cortical excitatory neurons. We identify transcriptional programs expressed during early neurogenesis in vitro and in human foetal cortex that are down-regulated in DLG2

Indexed as

Gene Expression Regulation, DevelopmentalNeurogenesisAnimalsCell DifferentiationCerebral CortexFemaleGene Knockdown TechniquesGenetic Predisposition to DiseaseGuanylate KinasesHuman Embryonic Stem CellsHumansMental DisordersNeuronsPregnancySchizophreniaTranscriptomeDLG2 protein, humanGuanylate KinasesTumor Suppressor Proteins

Identifiers

PMID35031607
PMCPMC8760302
OpenAlexW4205514065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.